Group Nierkens

Medicijnen en Levenswetenschappen

1. Allogeneic Cells 100%
2. Cell Transplantation 88%
3. T-Lymphocytes 75%
4. Immunologic Monitoring 69%
5. Dendritic Cells 67%
6. Immunotherapy 64%
7. Cell- and Tissue-Based Therapy 59%
8. Pediatrics 50%
9. Neuroblastoma 49%
10. Fetal Blood 49%
11. Clofarabine 41%
12. endothelial PAS domain-containing protein 1 40%
13. CD19 Antigens 39%
14. CRISPR-Associated Protein 9 38%
15. Semaphorins 35%
16. Systemic Scleroderma 34%
17. Chimeric Antigen Receptors 33%
18. fludarabine 32%
19. Mouse Sema3b protein 32%
20. Precursor Cell Lymphoblastic Leukemia-Lymphoma 31%
21. Antilymphocyte Serum 31%
22. Gene Editing 30%
23. Drug Monitoring 28%
24. Clustered Regularly Interspaced Short Palindromic Repeats 28%
25. Neoplasms 28%
26. Graft vs Host Disease 26%
27. Blood Cells 26%
28. Stem Cell Transplantation 26%
29. Survival 25%
30. Systemic Lupus Erythematosus 23%
31. Monocytes 23%
32. Arthritis 21%
33. Synoviocytes 21%
34. Pharmacokinetics 21%
35. Ligands 21%
36. Rheumatoid Arthritis 20%
37. Leukemia 20%
38. Fibrosis 20%
39. Young Adult 20%
40. Reactive Oxygen Species 19%
41. Hypoxia 19%
42. Cytokines 18%
43. Central Nervous System 18%
44. Bone Marrow 18%
45. Body Surface Area 17%
46. Child 17%
47. Down-Regulation 17%
48. Major Histocompatibility Complex 16%
49. Genes 16%
50. Therapeutics 16%
51. Fibroblasts 15%
52. Mutation 13%
53. Interleukin-2 13%
54. Mortality 13%
55. Recurrence 12%
56. Body Weight 11%
57. Myofibroblasts 11%
58. Serum 11%
59. Tumor Microenvironment 11%
60. Population 10%
61. B-Lymphocytes 10%
62. Transplantation Conditioning 10%
63. Arthralgia 9%
64. Granulocyte-Macrophage Colony-Stimulating Factor 9%
65. Endothelial Cells 9%
66. Hematopoietic Stem Cells 9%
67. Hematopoietic Stem Cell Transplantation 8%
68. Interleukin-12 8%
69. Immune Reconstitution 8%
70. Glomerular Filtration Rate 7%
71. Morbidity 7%
72. Confidence Intervals 7%
73. Molecular Probes 6%
74. tisagenlecleucel 6%
75. Transplants 5%
76. Natural Killer Cells 5%
77. Bleomycin 5%
78. Skin 5%
79. Area Under Curve 5%
80. Toll-Like Receptors 5%
81. Lung 5%
82. Regeneration 5%
83. Flow Cytometry 5%